Business● Low19m ago · Nov 10, 2026, 9:02 AM
Definium plans DT120 NDA filing in H1 2027 as cash runway extends into 2030
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Definium plans to file its DT120 New Drug Application in the first half of 2027, as its cash runway is projected to last until 2030. This indicates the company's financial stability and product development timeline.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business19m agoLifeVantage outlines $3M-$3.5M annualized platform spend as it plans 2027 digital launchesSeeking Alpha TechBusiness21m agoRichard Li’s FWD sets world record with sale of US$318m life insurance policySouth China Morning PostBusiness29m agoQuantum projects fiscal Q3 2027 revenue of $91M±$2M while targeting 43% gross margin in 18 monthsSeeking Alpha TechBusiness36m agoHesai Group reports mixed Q3 results; gives Q4 outlookSeeking Alpha Tech